| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | Chief Accounting Officer | Stock Option (right to buy) | 16,600 | 15 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | 15 Feb 2023 | 1 | $0 | 4 | Chief Accounting Officer | 17 Feb 2023, 18:23 |
| ANTX | AN2 Therapeutics, Inc. | 12 May 2022 | 1 | $0 | 4 | Chief Accounting Officer | 16 May 2022, 21:21 |
| ANTX | AN2 Therapeutics, Inc. | 24 Mar 2022 | 0 | $0 | 3 | Chief Accounting Officer | 24 Mar 2022, 21:23 |